ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
Promoter entity Essix Biosciences Limited acquired 70,00,000 fully convertible warrants of Ind-Swift Laboratories via a preferential allotment.
Ind-Swift Laboratories allotted 70 lakh fully convertible warrants at Rs. 196 each, totaling Rs. 137.2 Crore. This preferential issue will augment capital upon warrant conversion.
Ind-Swift Laboratories Limited allotted 70,00,000 fully convertible warrants to Essix Biosciences Limited on a preferential basis. The company received Rs. 34.30 Crore as upfront payment.
Ind-Swift Laboratories' Preferential Issue Committee approved a revised issue price of Rs. 196 per warrant. The pricing follows SEBI ICDR regulations and a revised valuation report.
Ind-Swift Laboratories issued a corrigendum to its EGM notice regarding a preferential issue of 70,00,000 warrants, detailing the utilization of Rs. 137.20 Crore in proceeds.
Ind-Swift Laboratories approved a Rs. 137.20 Crore preferential issue of 70 lakh warrants to Essix Biosciences Limited. Warrants are convertible within 18 months.